Company Overview
About Reshape Biotech
Reshape Biotech is a Copenhagen, Denmark-based laboratory automation robotics company — backed by Y Combinator (W21) with $28.2 million in total funding including a $20 million Series A led by Astanor Ventures in April 2024 with participation from YC — providing biotechnology companies, life sciences research organizations, and food technology companies with specialized single-function robots that automate repetitive microbiological laboratory workflows, generating $8.3 million in annual revenue in 2024 with a 55-person team. Reshape's robots have saved customers over 500,000 hours of manual lab work annually, serving the sustainable food technology and alternative protein sector (fermentation-based food production, precision fermentation, cultivated meat) alongside traditional biotech research laboratories that use microbiology workflows at scale.
Business Model & Competitive Advantage
Reshape Biotech's robot design philosophy ('one robot, one task') addresses the ergonomics and accuracy failure modes of manual microbiological workflows: the tedious, repetitive nature of tasks like inoculating hundreds of culture plates, filling growth media into multi-well plates, or analyzing colonies under microscopes creates both human error (accuracy degrading with fatigue on repetitive tasks) and ergonomic injury risk for laboratory workers performing thousands of pipetting motions per shift. Reshape builds dedicated robots optimized specifically for each workflow — the Reshape Plate Filler (automated liquid handling into culture plates), the Reshape Streaker (automated bacterial streaking for colony isolation), and the Reshape Colony Counter (AI-powered image analysis for colony counting and classification) — rather than attempting general-purpose lab automation that trades depth for breadth. The mechatronics engineering (compact robotic hardware designed for standard lab bench footprints) and machine learning image analysis (interpreting microscopy and plate imaging data with expert-level accuracy) combine to create the accuracy and throughput improvements that justify capital investment.
Competitive Landscape 2025–2026
In 2025, Reshape Biotech competes in the laboratory automation, life sciences robotics, and biotech lab equipment market with Hamilton Robotics (Hamilton Company, liquid handling robots), Azenta Life Sciences (NASDAQ: AZTA, integrated biobanking and lab automation), and Opentrons (accessible lab automation robots, $200M raised) for biotech laboratory team workflow automation adoption. The sustainable food technology market (alternative proteins, precision fermentation) has grown rapidly as food companies invest in fermentation-based manufacturing that uses the same microbiology workflows (plating, counting, inoculating) as pharmaceutical biotech — creating a new customer segment for lab automation beyond traditional drug discovery. Astanor Ventures' food system investment focus (Astanor is a leading food and agriculture technology VC) reflects the sustainable food tech application of Reshape's platform. Y Combinator W21 backing connected Reshape with the life sciences and climate tech investor community. The 2025 strategy focuses on growing the alternative protein and precision fermentation customer base, building the automated microbiology workflows for industrial fermentation process development, and expanding the robot-as-a-service subscription model for laboratory teams without capital equipment procurement budgets.
Recent Activity
View all →Key Differentiators
Strong Challenger
Reshape Biotech is an established challenger with significant market presence and competitive offerings in Healthcare.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Browser Use
Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
Compare Reshape Biotech with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Reshape Biotech? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Reshape Biotech Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Reshape Biotech vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →